5. Market analysis

17
Marketability Wednesday, May 18, 2016 XOHW16 MEETING, NECSTLab BEye project presentation Marco Bacis Lara Cavinato Irene Fidone - [email protected] - [email protected] - [email protected]

Transcript of 5. Market analysis

Marketability

Wednesday,May18,2016XOHW16MEETING,NECSTLab

BEyeprojectpresentation

Marco Bacis Lara Cavinato Irene Fidone

- [email protected] [email protected] [email protected]

Outline

Marketoverview

• Context• Solution

Benefitsofprevention

• Impactofcosts• Diagnosis speed up• Usability

Potentialcostumers

• Public• Private

MarketAnalysis

2

Outline

Marketoverview

• Context• Solution

Benefitsofprevention

• Imapct ofcosts• Diagnosis speed up• Usability

Potentialcostumers

• Public• Private

MarketAnalysis

3

Marketoverview

➢ 0,22%ofthepopulation isblind

➢ 14%isduetodiabeticretinopathy

Blindnessdata[1]

❖ Diabeticpeoplecontractthediabeticretinopathy - 100%seriouscase/60%mildcase

❖ Percentagesrelatedtoage:

❖ After15yearsofdiseasepatientsget(almost)blind

Diabetesdata[2]

➢ Under50→12%➢ 50-59aged→19%➢ Over60→24%

[1]http://www.salute.gov.it/portale/temi/p2_6.jsp?id=2389&area=prevenzioneIpovisione&menu=prevenzione [2]http://www.iapb.it/news2.php?id=1386

4

Marketoverview

➢ Mildcases:drugs

➢ Seriuscases:laserphotocoagulation

➢ Veryseriuscases:intravitrealinjections

Medicaltreatments

5

Solution

➢ Studieshaveshownhowimportant testsareindiseaseprevention

➢ 50%ofcasesofblindnesscanbeavoidedbypreventing

Ithasbeenestimatedthatsystematicscreeningfordiabeticretinopathycouldpreventaround260newcasesofblindnesseachyearamongpeopleagedunder70inEnglandandWales[4].

➢ Savingtime&&money

Screeningdata[3]

[3] Effectiveness of screening and monitoring tests for diabetic retinopathy ± a systematic review A. Hutchinson*, A. McIntosh*, J. Peters*, C. O'Keeffe*, K. Khunti2, R. Baker2 and A. Booth3 ,200.[4] Complications of diabetes: screening for retinopathy and management of foot ulcers A.Melville, R.Richardson, A.McIntosh, C.O’KeeVe, J.Mason, J. Peters, A.Hutchinson

6

Currentscreeningtests

Testareperformendonlyinhospitalsandbyqualifiedstaff

Nowadays...

7

CurrentscreeningtestsNowadays...

Itisrequired:● Longtime:waitinglistandpossiblySWelaboration● Highcost:specificequipmentandhighly qualified staff

8

...Ouridea

FPGAprocessor Tablet Camera

● Automateddiagnosis

● Portable

● Possible realtimediagnosis

Proposeddevice

9

POSITIONING:

speedupprocessesautomateddiagnosis

PROMISE:

Efficacyandspeedthanttraditional

methods

PRODUCT:

asupport forabetterdiagnosisandtolowercosts

PERSONALITY:

replaceobsoletemethodsandreachmorepeopleas

possible

PERSONALITY:

replaceobsoletemethodsandreachmorepeopleas

possible

Brandpositioning

10

Outline

Marketoverview

• Context• Solution

Benefitsofprevention

• Impactofcosts• Diagnosis speed up• Usability

Potentialcostumers

• Public• Private

MarketAnalysis

11

576.576.000€ / year for absolute blindness pensionsof public spending

Impact of costsBenefitsofprevention

184.800 blind people due to diabetic retinopathy in Italy

12

Easy to use.High qualified staff it isnot necessary for first diagnosis

Portable

http://www.thinkstockphotos.it/image/stock-illustration-travel-bags/497446306

BenefitsofpreventionUsability

13

Possibility of shorten waiting lists

Try to reach more people as possible

BenefitsofpreventionDiagnosis Speed up

14

Outline

Marketoverview

• Context• Solution

Benefitsofprevention

• Imapct ofcosts• Diagnosis speed up• Usability

Potentialcostumers

• Public• Private

MarketAnalysis

15

Public: Private:

Medical Offices Laboratories of analysis

Pharmacies

Potentialcustomers

16

[email protected]

[email protected]

[email protected]

Emails

Facebook https://www.facebook.com/beye.project/

Twitter https://twitter.com/BEye_NECSTLab

Politecnico di Milano, NECST lab for Xilinx Open Hardware Contest 2016 #XOHW16

17